Start: April 18, 2019
End: June 30, 2025
Transcranial magnetic stimulation (TMS) is a noninvasive procedure that involves the use of magnetic fields to stimulate areas of the brain. This study will test different doses and applications of TMS in adults with and without mild cognitive impairment (MCI), a precursor to Alzheimer's disease. Participants will first undergo two separate sessions in which they receive continuous or intermittent stimulation to determine the optimal protocol for them based on memory tasks. Participants will then undergo 30-minute stimulation sessions Monday through Friday for four weeks. They will also participate in several two- to three-hour testing sessions involving brain imaging, neuropsychological testing, memory tasks, and other assessments throughout the study.
Minimum Age: 50 Years
Maximum Age: 80 Years
Contact study personnel listed either under the general study contact or the location nearest you.
Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.
Bioscience Research Laboratory
Tucson, AZ 85719
Lead: University of Arizona
Source: ClinicalTrials.gov ID: NCT03962959